Los Angeles Business Journal

Valeant to Buy Obagi Medical

Wednesday, March 20, 2013

Canadian drugmaker Valeant Pharmaceuticals International Inc. today said it would buy Long Beach's Obagi Medical Products Inc. for about $344 million to boost its dermatology business, Reuters reports. Obagi makes physician-prescribed skin-care products.